Kialo requires cookies to work correctly.
Should medical research embrace racial differences in treatment efficacy?
Medical research should embrace racial differences in treatment efficacy
Given some diseases are more common among people of particular races, it might make sense to test patients for those diseases based on their race.
Assuming that all treatment and medicine prescribed from this research have undergone thorough testing and are supported by evidence, this could lead to greater time efficiencies and reduced costs for the medical world.
Treatment efficacy is affected by a large number of variables, including race.
Diseases can present with different symptoms in people of different races.
Clinical trials rarely enroll
numbers of people of color. If pharmaceutical companies embraced racial differences in treatment efficacy they would be able to collect more data concerning how different racial groups are affected by different types of treatment.
This will result in the financial
by pharmaceutical companies of racial minorities.
It would be dangerous to assume that racial categories map neatly onto medically useful biological categories.
Searching for innate racial differences between patients can
and researchers from other, more important differences (like socioeconomic status), which cause far more medical problems than race, and whose overlap with race is largely (medically) coincidental.
' is a superior approach to race based medicine, and renders race based approaches moot.
If the medical community takes actions which suggest that races are fundamentally different, this will validate the beliefs of white supremacists and racists.
If it were widely known that race was used as a factor in medical treatment, it could create distrust between racial minorities and the medical community.
Who should have the final say about a child's medical treatment - doctors or parents?
Should cannabis be legalised for medical use in the UK?
Should Racial Profiling Be Banned?